There is a risk of overdose.
In a press release published on May 6, the drug agency announces the recall of several lots of a drug prescribed against high blood pressure. “We were informed by the Viatris laboratory of a printing defect on the plates of several lots that can induce a risk of overdose” explains the authority. The inscription presents on the aluminum of the brochure suggests that it is necessary to take several tablets on certain days which promotes the risk of a surplus taking.
Pharmacists must “Join the patients who have received one or more boxes from these lots, by all the means they have”. The boxes must be paid to the pharmacy to exchange an equivalent specialty so as not to stop the treatment. The prizes recalled were distributed from March 2024. These are precisely four lots of Lisinopril 5 mg Viatris:
- Box of 28 tall tablets: lot 8172295, Epremption 01/2026 and Lot 8189879, Epremption 03/2027;
- Box of 84 Silly tablets: Lot 8172296, Employment 01/2026 and Lot 8192737, Event 03/2027.
The 20 mg dosage is not affected by this defect. If in doubt, report the pharmacy box where a pharmacist will check the lot number. In case of overdose, the patient may feel fatigue, balance disorders, hypotension. An alteration of the renal function can also occur. These side effects can be stronger if you suffer from kidney failure. “If you feel adverse effects, contact a doctor” recommends the ANSM. On date, the agency was aware of a single case of overdose accompanied by a confusional state “Not serious”.
Lisinopril belongs to the class of inhibitors of the angiotensin conversion enzyme (IEC). It acts by dilating the blood vessels, which helps to lower blood pressure and facilitates the work of the heart to send the blood in all parts of the body. It is indicated in the event of too high blood pressure (high blood pressure), heart failure, recent heart attack and kidney problems in the event of type II diabetes and high blood pressure.
